Oxytocin
Oxytocin is a peptide hormone used medically in obstetrics, distinct from wellness or bonding claims.
Approvals
Peptipedia explains research and prescribing information. It does not replace medical advice and is not an invitation to use a substance.
Research areas
Evidence matrix
- Molecular identity
- Confirmed
Oxytocin is a defined nonapeptide hormone. The approved evidence applies to PITOCIN in monitored obstetric settings.
- Human research
- Strong
- Replication
- No independent replication
- Clinical endpoints
- Hard patient-relevant outcomes
- Safety
- Characterized by prescribing information or extensive studies
- Approval
- US · Approved
The dimensions are presented separately and are not combined into an overall score.
What the source shows
PITOCIN is used in defined obstetric situations under clinical monitoring.
- PITOCIN: US prescribing informationPrescribing information2026
U.S. National Library of Medicine (DailyMed)
Accessed:
Research gaps
- ·This approval does not establish general improvements in social bonding.
- ·Short profile: not a complete benefit–risk assessment. Unlisted contraindications and interactions are not adequately established in this profile; missing information does not establish safety.
Mechanism
It stimulates uterine smooth muscle.
- PITOCIN: US prescribing informationPrescribing information2026
U.S. National Library of Medicine (DailyMed)
Accessed:
Study protocols
No sufficiently supported, exactly citable study protocols are available.
Reported adverse effects
- ·Serious risks include uterine hyperstimulation and water intoxication.
Contraindications and warnings
- ·For antepartum use, PITOCIN is contraindicated in circumstances including an undeliverable fetal presentation, fetal distress when delivery is not imminent, a hyperactive uterus, or when vaginal delivery is contraindicated.
Interactions
- ·According to the PITOCIN label, vasoconstrictors after caudal-block anesthesia and cyclopropane anesthesia can contribute to serious cardiovascular reactions.
Research gaps
- ·This approval does not establish general improvements in social bonding.
- ·Short profile: not a complete benefit–risk assessment. Unlisted contraindications and interactions are not adequately established in this profile; missing information does not establish safety.
- PITOCIN: US prescribing informationPrescribing information2026
U.S. National Library of Medicine (DailyMed)
Accessed:
Sources
Sources checked: · Version 2
- PITOCIN: US prescribing informationPrescribing information2026
U.S. National Library of Medicine (DailyMed)
Accessed: